This is not the most recent version of the article. View current version (1 NOV 2014)

Intervention Protocol

You have free access to this content

Non-pharmacological interventions for somatoform disorders and medically-unexplained physical symptoms (MUPS) in adults

  1. Nikki Van Dessel1,*,
  2. Madelon Den Boeft1,
  3. Johannes C van der Wouden2,
  4. Maria Kleinstäuber3,
  5. Stephanie S Leone4,
  6. Berend Terluin1,
  7. Mattijs E Numans5,
  8. Henriëtte E van der Horst1,
  9. Harm van Marwijk2

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 16 JUN 2014

DOI: 10.1002/14651858.CD011142


How to Cite

Van Dessel N, Den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H. Non-pharmacological interventions for somatoform disorders and medically-unexplained physical symptoms (MUPS) in adults (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No.: CD011142. DOI: 10.1002/14651858.CD011142.

Author Information

  1. 1

    EMGO Institute for Health and Care Research, VU University Medical Center, Department of General Practice and Elderly Care Medicine, Amsterdam, Netherlands

  2. 2

    VU University Medical Center, Department of General Practice and Elderly Care Medicine, EMGO Institute for Health and Care Research, Amsterdam, Netherlands

  3. 3

    Philipps-University Marburg, Department of Clinical Psychology and Psychotherapy, Marburg, Hessen, Germany

  4. 4

    Netherlands Institute of Mental Health and Addiction (Trimbos Institute), Department of Public Mental Health, Utrecht, Netherlands

  5. 5

    LUMC, Department of Public Health and Primary Care, Leiden, Netherlands

*Nikki Van Dessel, Department of General Practice and Elderly Care Medicine, EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, room D-550, Amsterdam, 1081 BT, Netherlands. n.vandessel@vumc.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 16 JUN 2014

SEARCH

This is not the most recent version of the article. View current version (01 NOV 2014)

References

Additional references

Allen 2002
  • Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosomatic Medicine 2002;64:939-50.
Altman 1996
American Psychiatric Association 1980
  • American Psychiatric Association. Diagnostic and statistical manual of mental health disorders. 1st Edition. Washington DC, USA: American Psychiatric Association, 1980.
American Psychiatric Association 2000
  • American Psychiatric Association. Diagnostic and statistical manual of mental health disorders. 4th Edition. Washington DC, USA: American Psychiatric Association, 2000.
American Psychiatric Association 2013
  • American Psychiatric Association. Diagnostic and statistical manual of mental health disorders. 5th Edition. Washington DC, USA: American Psychiatric Association, 2013.
Beck 1961
Beck 1988
  • Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology 1988;56(6):893–97.
Bernardy 2013
Busch 2007
Deary 2007
Deeks 2008
  • Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publishing Group, 2008.
Derogatis 1983
  • Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychological Medicine 1983;13:596–605.
Derogatis 1986
  • Derogatis LR. The SCL-90-R: Administration, Scoring, and Procedures Manual II. Towson MD: Clinical Psychometric Research, 1986.
Dimsdale 2009
  • Dimsdale J, Creed F. The proposed diagnosis of somatic symptom disorders in DSM-V to replace somatoform disorders in DSM-IV - a preliminary report. Journal of Psychosomatic Research 2009;66:473-6.
Edwards 2010
  • Edwards TM, Stern A, Clarke DD, Ivbijaro G, Kasney LM. The treatment of patients with medically unexplained symptoms in primary care: a review of the literature. Mental Health in Family Medicine 2010;7:209-21.
Escobar 1987
Escobar 1998
Fink 2007
  • Fink P, Toft T, Hansen MS, Ørnbøl E, Olesen F. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosomatic Medicine 2007;69:30-9.
First 2002
  • First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. New York: Biometrics Research, New York State Psychiatric Institute, 2002.
Ford 2009
  • Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009;58:367–78.
Gamble 2005
Goldberg 1989
Guerney 1971
  • Guerney B, Stollak G, Guerney L. The practicing psychologist as educator - an alternative to the medical practitioner model. Professional Psychology 1971;2:271-2.
Gureje 1997
Guy 1976
  • Guy W. ECDEU Assessment Manual for Psychopharmacology - Revised. Rockville, MD: Psychopharmacology Research Branch, Division of Extramural Research Programs, US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, 1976:218-22.
Hakkaart 2002
  • Hakkaart-van Roijen L. Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P). Rotterdam: Institute for Medical Technology Assessment, Erasmus University, 2002.
Hall 1995
Hamilton 1959
Hamilton 1960
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hoedeman 2010
Ipser 2009
Janca 1996
Kellner 1986
  • Kellner R. Somatization and Hypochondriasis. JAMA. New York: Praeger Publishers, 1987:322-4.
Kihlstrom 1985
Kirmayer 2004
Kleinstäuber 2011
  • Kleinstäuber M, Witthöft M, Hiller W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clinical Psychology Review 2011;31:146-60.
Kleinstäuber 2013
  • Kleinstäuber M, Witthöft M, Steffanowski A, Lambert M, Meinhardt G, Lieb K, et al. Pharmacological interventions for somatoform disorders in adults. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD010628]
Konnopka 2012
  • Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M, Herzog W, et al. Economics of medically unexplained symptoms: a systematic review of the literature. Psychotherapy and Psychosomatics 2012;81:265-75.
Kroenke 1989
Kroenke 1997
  • Kroenke K, Spitzer RL, deGruy FV, Hahn SR, Linzer M, Williams JB, et al. Multisomatoform disorder: an alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Archives of General Psychiatry 1997;54:352-8.
Kroenke 2000
Kroenke 2002
Lindstrom 1992
  • Lindström I, Öhlund C, Eek C, Wallin L, Peterson LE, Fordyce WE, et al. Mobility of graded activity on patients with subacute low back pain: a randomised prospective clinical study with operant-conditioning behavioural approach. Physical Therapy 1992;4:279-93.
Loew 2000
  • Loew TH, Sohn R, Martus P, Tritt K, Rechlin T. Functional relaxation as a somatopsychotherapeutic intervention: a prospective controlled study. Alternative Therapies in Health and Medicine 2000;6(6):70-5.
Malouff 2007
  • Malouff JM, Thorsteinsson EB, Schutte NS. The efficacy of problem solving therapy in reducing mental and physical health problems: a meta-analysis. Clinical Psychology Review 2007;27(1):46-57.
Moher 2009
Moore 2011
  • Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD007938]
Mumford 1991
  • Mumford DB. The development and validation of the Bradford Somatic Inventory: an investigation of functional somatic symptoms in Britain and Pakistan. MD Thesis, University of Bristol, UK 1991.
Nanke 2003
Nezu 2001
  • Nezu AM, Nezu CM, Lombardo ER. Cognitive-behavior therapy for medically unexplained symptoms: a critical review of the treatment literature. Behavior Therapy 2001;32:537-83.
Noyes 2008
Pae 2009
  • Pae CU, Marks DM, Patkar AA, Masand PS, Luyten P, Serretti A. Pharmacological treatment of chronic fatiguesyndrome: focusing on the role of antidepressants. Expert Opinion on Pharmacotherapy 2009;10:1561–70.
Pilowsky 1967
Price 2008
RevMan 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rief 1997
  • Rief W, Hiller W, Heuser J. SOMS: screening for somatoform disorders [SOMS: das screening für somatoforme störungen.]. SOMS: Das screening für somatoforme störungen. [SOMS: screening for somatoform disorders]. Bern: Huber, 1997.
Rief 2003
Ring 2004
  • Ring A, Dowrick C, Humphris G, Salmon P. Do patients with unexplained physical symptoms pressurise general practitioners for somatic treatment? A qualitative study. BMJ 2004;328(7447):1057.
Rosendal 2013
Ruddy 2005
Saarto 2007
Schwartz 2003
  • Schwartz MD, Andrasik F. Biofeedback: A Practitioner’s Guide. 3rd Edition. New York: Guilford Publications, 2003.
Schünemann 2008
  • Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al for the GRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008;336(7653):1106-10.
Sharpe 1992
Sheehan 1983
  • Sheehan DV. The Anxiety Disease. New York: Charles Scribner and Sons, 1983.
Sheehan 1998
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998;59; suppl. 20:22-33.
Silberstein 2002
Smith 1986
  • Smith GR, Monson RA, Ray DC. Patients with multiple unexplained symptoms: their characteristics, functional health, and health care utilization. Archives of Internal Medicine 1986;146(Jan):69-72.
Spitzer 1990
  • Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R. Patient/non-patient. Washington DC: American Psychiatric Press, 1990.
Sterne 2011
  • Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
Sumathipala 2007
  • Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosomatic Medicine 2007;69:889-900.
Terluin 2006
  • Terluin B, van Marwijk HWJ, Adèr HJ, de Vet HCW, Penninx BWJH, Hermens MLM, et al. The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry 2006;6:34.
Thompson 2007
van Ravensteijn 2013
  • van Ravensteijn H, Lucassen P, Bor H, van Weel C, Speckens A. Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: a randomized controlled trial. Psychotherapy and Psychosomatics 2013;82:299-310.
Ware 1992
Weyerer 1994
WHO 1990
  • World Health Organization. Composite International Diagnostic Interview. 1.0. Geneva: World Health Organization, 1990.
World Health Organization 2004
  • World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 2nd Edition. Vol. 1, Geneva: World Health Organization, 2004.
World Health Organization 1975
  • World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 1st Edition. Geneva: World Health Organization, 1975.
Yancey 2012
Zijdenbos 2009
Zoccolillo 1986